The family history was negative for other cases of breast cancer or ovarian cancer, but DNA-testing for the BRCA1 and BRCA2 genes was offered based on a high grade serous ovarian tumour meeting at least the 10% likelihood threshold defined by UK NICE guidelines [5]. This evidence concerns the gene BRCA2 and breast carcinoma.